Skip to Main Content
I'm looking for
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
hidden1hidden2
Read more about our products for gentle burn care:
hidden1hidden2
References
1. Upton D, Solowiej K. Pain and stress as contributors to delayed wound healing. Wound Practice and Research 2010, Vol. 18(3).
2. Gee Kee EL, Kimble RM, Cuttle L, Khan A, Stockton KA. Randomized controlled trial of three burns dressings for partial thickness burns in children. Burns 2015, 41(5):946-955.
3. Silverstein P, Heimbach D, Meites H et al. An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream. J Burn Care Res 2011, 32(6): 617-626.
4. Gee Kee EL, Stockton K, Kimble RM et al. Cost-effectiveness of silver dressings for paediatric partial thickness burns: An economic evaluation from a randomized controlled trial. Burns 2017, 43(4): 724-732.
5. Aggarwala S, Harish V, Roberts S et al. Treatment of partial thickness burns: a prospective, randomised controlled trial comparing Biobrane, Acticoat, Mepilex Ag and Aquacel Ag. J Burn Care Res 2020, 42(5): 934-43.
6. Tang H, Lv G, Fu J et al. An open, parallel, randomized, comparative, multicenter investigation evaluating the efficacy and tolerability of Mepilex Ag versus silver sulfadiazine in the treatment of deep partial-thickness burn injuries. J Trauma Acute Care Surg 2015, 78(5): 1000-1007.
7/* Mepilex Ag – Up to 7 days wear time. Mepitel Ag – Up to 8 days wear time. Mepilex Transfer Ag – Up to 14 days wear time.
8. At dressing change
9. The following statement represents the personal opinion of the patient and should not be interpreted as medical advice or a factual assertion. The views, information, and/or opinions expressed in this presentation are solely those of the individuals involved and do not necessarily represent those of Mölnlycke Health Care AB ("Mölnlycke"). Mölnlycke does not provide any medical advice and this presentation shall not be perceived as medical advice. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment.--
10.
10 - Silverstein P. et al. Journal of Burn Care & Research. 2011:32(6): 617-26
Contact us